Estimating the cost of treating patients with liver cirrhosis at the Mexican Social Security Institute / Estimación de costos de la atención de pacientes con cirrosis hepática en el Instituto Mexicano del Seguro Social
Salud pública Méx
;
52(6): 493-501, Nov.-Dec. 2010. tab
Article
in English
| LILACS
| ID: lil-572709
ABSTRACT
OBJECTIVE. To estimate the annual cost of treating patients with cirrhosis at the Mexican Institute of Social Security (IMSS per its abbreviation in Spanish). MATERIAL AND METHODS. The annual cost of treating three stages of cirrhosis (Child-Pugh A, Child-Pugh B and Child-Pugh C) was estimated using micro-costing techniques and medical experts. These results were compared and contrasted with prices reported by IMSS. RESULTS. The annual cost of treatment, in USA dollars, by Child-Pugh stage was a) micro-costing results:
$1110.17 stage A, $549.55 stage B and $348.16 stage C; b) opinion of medical experts $1 633.64, $6564.04 and $19660.35, respectively; and c) IMSS costs $4269.00, $16949.63 and $30249.25, respectively. CONCLUSIONS. The cost of treating patients with cirrhosis is considerable, and costs increase as the disease worsens. Cost estimates vary depending on the source of information, and the methodology used. There are discrepancies between the procedures reported in medical records and treatment recommendations by IMSS liver experts.RESUMEN
OBJETIVO. Estimar el costo anual de atención de pacientes con cirrosis hepática en el Instituto Mexicano del Seguro Social (IMSS). MATERIAL Y MÉTODOS. Se estimó el costo de atención de la cirrosis en tres estadios de la enfermedad (Child Pugh A, Child Pugh B y Child Pugh C) mediante micro-costeo y consulta a expertos. Los resultados se compararon entre sí, y con los costos reportados por el IMSS. RESULTADOS. El costo anual de atención en dólares por estadio fue a) con microcosteo $1110.17 etapa A, $549.55 etapa B y $348.16 etapa C, respectivamente; b) mediante consulta a expertos $1633.64, $6564.04 y $19660.35, respectivamente; y c) con costos del IMSS $4269.00, $16949.63 y $30249.25, respectivamente. CONCLUSIONES. El tratamiento de cirrosis es costoso y generalmente los costos aumentan al avanzar la enfermedad. Además, los costos varían dependiendo de la fuente de información y la metodología utilizada. Existen diferencias entre los procedimientos reportados en los expedientes clínicos y el tratamiento recomendado por los hepatólogos del IMSS.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Social Security
/
Direct Service Costs
/
Academies and Institutes
/
Liver Cirrhosis
Type of study:
Practice guideline
/
Health economic evaluation
/
Observational study
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
Mexico
Language:
English
Journal:
Salud pública Méx
Journal subject:
Public Health
Year:
2010
Type:
Article
Affiliation country:
Mexico
/
United States
Institution/Affiliation country:
Instituto Mexicano del Seguro Social/MX
/
Instituto Nacional de Salud Pública/MX
/
UCLA/US
Similar
MEDLINE
...
LILACS
LIS